MedicineCancer BiologyOncologyApoptosisMolecular OncologyTranscriptomicsCancer GenomicsCancer Survival AnalysisCancer TranscriptomicsMolecular Tumor ProfilingNext-generation Sequencing In OncologyTranscriptomic ProfilingBreast Cancer PrognosisImmune Infiltration Prognostic SignaturesMicrosatellite Instability AnalysisMicrosatellite Instability PrognosisPrognostic BiomarkersPrognostic Expression SignaturesPrognostic ModelsPrognostic Prediction Models
Background: PANoptosis, a cell death pathway involving pyroptosis, apoptosis, and necroptosis, is pivotal in the development of malignancy. However, in the field of breast cancer, the interaction between PANoptosis and tumor cells has not been thoroughly explored. Methods: We downloaded breast cancer data and GSE176078 single-cell sequencing dataset from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases to obtain PANoptosis-associated genes. To construct prognostic models, COX and LASSO regression was used to identify PANoptosis-associated genes with prognostic value. Finally, immune infiltration analysis and differential analysis of biological functions were performed. Results: Risk grouping was performed according to the prognostic model constructed by COX regression and LASSO regression. The low-risk group showed a better prognosis (P < 0.05) and possessed higher levels of immune infiltration and expression of immune checkpoint-related genes. In addition, the lower the risk score, the higher the degree of microsatellite instability (MSI). Meanwhile, radixin (RDX), the gene with the highest hazard ratio (HR) value among PANoptosis prognosis-related genes, was explicitly expressed in artery Iendothelial cells (ECs) and was widely involved in signaling pathways such as immune response and cell proliferation, possessing rich biological functions. Conclusion: We demonstrated the potential of PANoptosis-based molecular clustering and prognostic features in predicting the survival of breast cancer patients. Furthermore, this study has led to a deeper understanding of the role of PANoptosis in breast cancer and has the potential to provide new directions for immunotherapy of breast cancer.
38
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia et al. · CA A Cancer Journal for Clinicians · 2022 · 3.7K citations · Full text
CellMarker: a manually curated resource of cell markers in human and mouse
Xinxin Zhang, Yujia Lan, Jinyuan Xu et al. · Nucleic Acids Research · 2018 · 1.7K citations · Full text
Dongqiang Zeng, Zilan Ye, Rongfang Shen et al. · Frontiers in Immunology · 2021 · 1.3K citations · Full text
Medicine, Immunology, Oncology +17